date:May 17, 2018
In compliance with Article 43 of Regulation （EC） No 396/2005, EFSA received from the European Commission a mandate to provide its reasoned opinion on the existing maximum residue levels （MRLs） for acetamiprid which might lead to consumers intake concerns on the basis of the new toxicological reference values agreed upon by Member States （MSs） in October 2017.
In order to identify the MRLs of potential concern that require a more detailed assessment, EFSA performed a preliminary risk a